Real-World Treatment Patterns and Economic Burden Following First-Line Trastuzumab in Patients with Metastatic Gastric Cancer in the USA

Real-World Treatment Patterns and Economic Burden Following First-Line Trastuzumab in Patients with Metastatic Gastric Cancer in the USA

Abstract Background Trastuzumab in combination with chemotherapy is the standard first-line (1L) treatment for HER2+ metastatic gastric cancer (mGC) in the USA. Objective This study characterizes the real-world treatment patterns, healthcare resource use (HRU), and costs in patients with HER2+ mGC p...

Full description

Bibliographic Details
Main Authors: Afsaneh Barzi, Feng Lin, Jinlin Song, Clara Lam, Xiaoyu Nie, Ahmed Noman, Winghan J. Kwong
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-08-01
Series:Drugs - Real World Outcomes
Online Access:https://doi.org/10.1007/s40801-023-00378-y

Internet

https://doi.org/10.1007/s40801-023-00378-y

Similar Items